Clinical Trials List
2025-06-01 - 2033-12-31
Phase III
Recruiting4
ICD-10E85.0
Non-neuropathic heredofamilial amyloidosis
ICD-10E85.1
Neuropathic heredofamilial amyloidosis
ICD-10E85.2
Heredofamilial amyloidosis, unspecified
ICD-10E85.3
Secondary systemic amyloidosis
ICD-10E85.4
Organ-limited amyloidosis
ICD-10E85.8
Other amyloidosis
ICD-10E85.9
Amyloidosis, unspecified
ICD-9277.3
Amyloidosis
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JEN-KUANG LEE Division of Cardiovascular Diseases
- 楊荔丹 Division of Cardiovascular Diseases
- HSUEH-WEN HSUEH Division of Neurology
- Ming-Jen Lee Division of Neurology
- Chi-Chao Chao Division of Neurology
- SUNG-TSANG HSIEH Division of Neurology
- CHO-KAI WU Division of Cardiovascular Diseases
- JYH-MING JIMMY JUANG Division of Cardiovascular Diseases
- 蔡承烜 Division of Cardiovascular Diseases
- 江君揚 Division of Cardiovascular Diseases
- CHIA-TI TSAI Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Chun Lee Division of Neurology
- 郭泠 Division of Cardiovascular Diseases
- 季康揚 Division of Neurology
- 黃偉銘 Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- 張皓智 Division of Cardiovascular Diseases
- Kon-Ping Lin Division of Neurology
- 廖若男 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃祺耀 Division of Cardiovascular Diseases
- WEI-WEN LIN Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
1250 participants
